Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jun 18, 2026 · Filed Jun 23, 2026
Hims & Hers Health's Chief Medical Officer sold $830K of Hims & Hers Health shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$830,410
Shares × reported transaction price
38 days after results of May 11, 2026, 53 days before results of Aug 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +14.9% | +1.7% | +13.2% |
| 30 days | −14.1% | +0.8% | −14.9% |
| 90 days | −6.9% | +5.5% | −12.4% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
CFO sold ~$229K of Hims & Hers Health
Scheduled in advanceDerivative exercise or conversion — not an open-market buy.